Combining X-ray Crystallographyand MolecularModeling toward the Optimization of Pyrazolo[3,4-d]pyrimidines as Potent c-Src Inhibitors Active in Vivo againstNeuroblastoma.

MLA

Tintori, Cristina, et al. “Combining X-Ray Crystallographyand MolecularModeling toward the Optimization of Pyrazolo[3,4-d]Pyrimidines as Potent c-Src Inhibitors Active in Vivo AgainstNeuroblastoma.” Journal of Medicinal Chemistry, vol. 58, no. 1, Jan. 2015, pp. 347–61. EBSCOhost, https://doi.org/10.1021/jm5013159.

APA

Tintori, C., Fallacara, A. L., Radi, M., Zamperini, C., Dreassi, E., Crespan, E., Maga, G., Schenone, S., Musumeci, F., Brullo, C., Richters, A., Gasparrini, F., Angelucci, A., Festuccia, C., Delle Monache, S., Rauh, D., & Botta, M. (2015). Combining X-ray Crystallographyand MolecularModeling toward the Optimization of Pyrazolo[3,4-d]pyrimidines as Potent c-Src Inhibitors Active in Vivo againstNeuroblastoma. Journal of Medicinal Chemistry, 58(1), 347–361. https://doi.org/10.1021/jm5013159

Chicago

Tintori, Cristina, Anna Lucia Fallacara, Marco Radi, Claudio Zamperini, Elena Dreassi, Emmanuele Crespan, Giovanni Maga, et al. 2015. “Combining X-Ray Crystallographyand MolecularModeling toward the Optimization of Pyrazolo[3,4-d]Pyrimidines as Potent c-Src Inhibitors Active in Vivo AgainstNeuroblastoma.” Journal of Medicinal Chemistry 58 (1): 347–61. doi:10.1021/jm5013159.